(-)-Dipivaloyl-L-tartaric Acid>98.0%(HPLC)(T)5g

3-Nitrobenzenesulfonic Acid>98.0%(HPLC)(T)5g

Benzo[h]quinazolin-2-amine, 6-(2-fluorophenyl)-5,6-dihydro-N-[3-[2-[(2-methoxyethyl)amino]ethyl]phenyl]-, (6R)-, 99%, 10mg

(trans,trans)-3,4-Difluorophenyl 4'-propyl-[1,1'-bi(cyclohexane)]-4-carboxylate, 97.0%, 5g

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(2-(((tert-butoxycarbonyl)amino)methyl)phenyl)propanoic acid, 95+%, 500mg

(2E)-1-(4-bromophenyl)-3-(2,5-dimethoxyphenyl)prop-2-en-1-one, 95.0%, 2g

tert-Butyl 4-(aminomethyl)-4-hydroxy-piperidine-1-carboxylate hydrochloride, 98%, 5g

(S)-2-Amino-3-(5-methoxy-1H-indol-3-yl)propanoic acid, 95.0%, 100mg

(1R,2R)-Dimethyl cyclohexane-1,2-dicarboxylate, 95.0%, 250mg

n-Pentane, min. 95%, purest, 5 l, aluminum

MagSi-Direct 3.0, 2 ml beads

Z-NMe-L-norleucine, 500mg

[(2-phenyl-1,3-thiazol-4-yl)methyl]amine dihydrochloride, 95.0%, 5g